Winchester, MA, United States of America

Jifeng Liu

This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: 1Globe Biomedical Co., Ltd., 1Globe Health Institute LLC, Arqule, Inc.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jifeng Liu. Retrieved from https://idiyas.com/inventor/jifeng-liu-ygovxcnu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 26(Granted Patents)

Company Filing History:

3 out of 10

1Globe Biomedical Co., Ltd.

patents

3 out of 11

1Globe Health Institute LLC

Boston Biomedical, Inc.

patents

5. 1 out of 1

Globe Biomedical Co., Ltd.

patent

6. 1 out of 1

Globe Health Institute LLC

patent

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12390460 - Treatment for obesity (2025-08-19),

2. 12318381 - Treatment for non-alcoholic fatty liver disease (2025-06-03),

3. 12091378 - Therapeutics for central nervous system disorders (2024-09-17),

4. 11370748 - Therapeutics for central nervous system disorders (2022-06-28),

5. 9745278 - Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors (2017-08-29),

6. 8232285 - Quinazolinone compounds and methods of use thereof (2012-07-31),

7. 7902192 - Inhibitors of P38 and methods of using the same (2011-03-08),

Title: The Innovative Contributions of Jifeng Liu

Introduction

Jifeng Liu is a prominent inventor based in Winchester, MA, known for his significant contributions to medical science. With a total of seven patents to his name, Liu has focused on developing novel treatments for critical health issues, particularly obesity and liver diseases.

Latest Patents

Among his latest patents, Liu has developed a treatment for obesity, which provides innovative methods for treating or preventing obesity and its associated comorbidities in mammals, including humans. Additionally, he has created a treatment for non-alcoholic fatty liver disease (NAFLD), which includes non-alcoholic steatohepatitis (NASH). These inventions highlight his commitment to addressing pressing health challenges.

Career Highlights

Throughout his career, Jifeng Liu has worked with notable organizations such as 1Globe Biomedical Co., Ltd. and 1Globe Health Institute LLC. His work in these companies has allowed him to advance his research and contribute to the field of medical innovation.

Collaborations

Liu has collaborated with several professionals in his field, including Chiang Jia Li and Syed M Ali. These partnerships have further enriched his research and development efforts.

Conclusion

Jifeng Liu's innovative work in developing treatments for obesity and liver diseases underscores his role as a significant contributor to medical science. His patents reflect a dedication to improving health outcomes for individuals worldwide.

Profile summary based on public USPTO records.